Our findings show that many have stepped back from some of those time-consuming therapies thanks to ETI." Scott Sagel, MD, PhD, lead author, professor of pediatrics-pulmonary medicine at the CU ...
WHIPPANY, N.J.--(BUSINESS WIRE)-- Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing ...
Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg levonorgestrel-releasing intrauterine system Mirena® for the ...
ORLANDO, Fla., Nov. 13, 2025 /PRNewswire/ -- Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of Conjugated Estrogens Tablets, USP, ...
Stage 2 endometrial cancer spreads to the cervical stroma but remains within the uterus and cervix, requiring precise staging and diagnosis. Treatment typically involves surgery, possibly a radical ...
Hosted on MSN
Bayer’s New Study on Mirena: A Potential Game-Changer for Endometrial Hyperplasia Treatment
Bayer AG ((BAYRY)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Tecentriq addition showed no significant OS benefit in advanced/recurrent endometrial cancer, except in dMMR patients with improved survival outcomes. PFS outcomes numerically favored Tecentriq across ...
One of this year's coveted Lasker Awards went to three scientists who helped invent a life-saving treatment for cystic fibrosis, a genetic disease. When you purchase through links on our site, we may ...
Brinsupri (brensocatib) is a new oral medicine approved to treat a long-term lung disease known as non-cystic fibrosis bronchiectasis (NCFB) in adults and children ages 12 or older. It works by ...
The National Institute for Health and Care Excellence (NICE) has recommended a combination treatment for advanced endometrial cancer, calling it a “major step forward.” This is the first time ...
Aug 4 (Reuters) - Vertex Pharmaceuticals (VRTX.O), opens new tab beat Wall Street estimates for quarterly results on Monday, helped by demand for its new cystic fibrosis drug and product launches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback